#United States #Minneapolis #Visura Technologies #TEECAD System #echocardiography technology

Visura Technologies Reveals Positive TEECAD Findings at ASE 2025 Conference

In an exciting development for the field of echocardiography, Visura Technologies, Inc. has presented positive outcomes from its TEECAD product registry at the 2025 American Society of Echocardiography (ASE) conference. This innovative technology significantly improves the safety and efficiency of transesophageal echocardiogram (TEE) probe intubations, offering real-time visualization that contrasts sharply with traditional blind intubation methods.

A Groundbreaking Presentation by Dr. Chad Olinger

The findings were unveiled by Dr. Chad Olinger, the President and Director of Echocardiography at the Metropolitan Heart and Vascular Institute in Minneapolis, who also serves as the Medical Director at Visura Technologies. "Nobody would go into a dark, foreign place without turning a light on," he stated, emphasizing how essential visual guidance is in medical procedures. Dr. Olinger believes that the data supports the adoption of TEECAD as a standard of care in echocardiography, enhancing physician confidence in safely intubating patients.

The TEECAD System: A Leap Forward in Medical Technology

The TEECAD System is the first FDA-cleared disposable camera that easily connects to a TEE probe. It provides high-resolution, real-time images of the laryngeal, esophageal, and gastric areas, enabling safer intubation and more effective probe placement. The study involved nearly 200 patients treated by 68 physicians across multiple healthcare settings, including echo labs, ICUs, and operating rooms. The data was collected using a standardized questionnaire from May 2024 to March 2025.

Key Findings from the TEECAD Registry

The positive results from the TEECAD registry highlight the system's substantial benefit:

• - Over 91% of attending physicians reported that the TEECAD System was advantageous for TEE probe placements.
• - Zero adverse events were recorded during TEECAD-guided intubations, which underscores its safety.
• - The navigation support provided by the TEECAD was rated "5" in nearly 80% of cases, indicating excellent usability.

These findings underline the TEECAD System's ability to provide visual confirmation of a clear path to the esophageal inlet, contrasting with traditional practices based solely on tactile feedback.

The Importance of Visual Guidance in TEE Intubations

Routine TEE intubations have traditionally relied on tactile guidance, which can lead to complications such as esophageal injury, especially in high-risk patients. The TEECAD System's real-time visualization offers a revolutionary approach that aligns with trends in other medical fields where visual assistance has become a standard practice. With over 1.7 million TEE procedures conducted annually in the U.S., the potential for TEECAD to enhance patient safety and reduce complications is massive.

Visura Technologies: Leading the Charge in Medical Innovation

As a privately held medical device company, Visura Technologies is dedicated to advancing visualization solutions to improve the safety and outcomes of TEE procedures. The TEECAD System represents a significant step forward in this mission, providing physicians with the tools necessary for first-pass intubation success. The system's adoption may help diminish costly complications associated with TEE, making it a game-changer for healthcare providers.

For further details, you can visit Visura's official website at www.visuratechnologies.com.

With advancements such as the TEECAD System, the future of echocardiography looks promising, and it could redefine how medical professionals approach TEE procedures, prioritizing patient safety and accuracy above all.